Alzheimer's disease is a vasocognopathy: a new term to describe its nature.
about
Omega-3 fatty acids: potential role in the management of early Alzheimer's diseaseHyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer diseaseRole of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer diseaseProtective role of S-nitrosoglutathione (GSNO) against cognitive impairment in rat model of chronic cerebral hypoperfusion.Low HDL Cholesterol is Associated with Lower Gray Matter Volume in Cognitively Healthy Adults.Vascular dysfunction associated with type 2 diabetes and Alzheimer's disease: a potential etiological linkage.Matrix metalloproteinase 2 (MMP-2) degrades soluble vasculotropic amyloid-beta E22Q and L34V mutants, delaying their toxicity for human brain microvascular endothelial cellsThe response of cerebral cortex to haemorrhagic damage: experimental evidence from a penetrating injury model.White matter injury due to experimental chronic cerebral hypoperfusion is associated with C5 deposition.Role of amyloid peptides in vascular dysfunction and platelet dysregulation in Alzheimer's diseaseExperimental microembolism induces localized neuritic pathology in guinea pig cerebrum.Cerebral Perfusion Enhancing Interventions: A New Strategy for the Prevention of Alzheimer Dementia.Correlation of CT perfusion and CT volumetry in patients with Alzheimer's disease.Cerebral amyloidosis: amyloid subunits, mutants and phenotypes.Activity of P-Glycoprotein, a β-Amyloid Transporter at the Blood-Brain Barrier, Is Compromised in Patients with Mild Alzheimer Disease.Expression of Tau protein in rats with cognitive dysfunction induced by cerebral hypoperfusionBiomarkers of vascular risk, systemic inflammation, and microvascular pathology and neuropsychiatric symptoms in Alzheimer's diseaseDisease staging and milestones.Age and apoE associations with complex pathologic features in Alzheimer's disease.Vascular cognitive deterioration and stroke.Pathophysiology of neuronal energy crisis in Alzheimer's disease.Is Alzheimer's disease amyloidosis the result of a repair mechanism gone astray?Role of serum response factor in the pathogenesis of disease.Alzheimer disease and cellular mechanisms of memory storage.Oxidative stress and metabolic syndrome: cause or consequence of Alzheimer's disease?Drug access to the central nervous system in Alzheimer's disease: preclinical and clinical insights.Thiazine Red(+) platelet inclusions in Cerebral Blood Vessels are first signs in an Alzheimer's Disease mouse model.Association of Central Arterial Stiffness and Pressure Pulsatility with Mild Cognitive Impairment and Dementia: The Atherosclerosis Risk in Communities Study-Neurocognitive Study (ARIC-NCS).A glycan-based approach to therapeutic angiogenesisCan brain impermeable BACE1 inhibitors serve as anti-CAA medicine?Effects of asiaticoside on human umbilical vein endothelial cell apoptosis induced by Aβ1-42.Impaired hypoxic tolerance in APP23 mice: a dysregulation of neuroprotective globin levels.CEREBRAL AMYLOID ANGIOPATHY AND ALZHEIMER'S DISEASE.Patterns of neuropsychological impairment in MCI patients with small subcortical infarcts or hippocampal atrophy.Change of Nrf2 expression in rat hippocampus in a model of chronic cerebral hypoperfusion.Novel Cortical Thickness Pattern for Accurate Detection of Alzheimer's Disease.Experimental chronic cerebral hypoperfusion results in decreased pericyte coverage and increased blood-brain barrier permeability in the corpus callosum.Risk factors associated with cognitive decline in the elderly with type 2 diabetes: pooled logistic analysis of a 6-year observation in the Japanese Elderly Diabetes Intervention Trial.Evaluation of Metabolic and Synaptic Dysfunction Hypotheses of Alzheimer's Disease (AD): A Meta-Analysis of CSF Markers.Are Major Dementias Triggered by Poor Blood Flow to the Brain? Theoretical Considerations.
P2860
Q24595490-A9E3784B-86A6-4E9E-93C5-3346E5C47EB9Q24657243-97943A61-EA77-45A7-B923-D12136A30EA4Q28586383-A2EA4DE7-F564-4F57-80FB-D05BA981576AQ33692827-8FE6FFAE-BDA6-42A2-BDF3-46CF2A1044D7Q34038935-C384F77A-CC1D-406C-95CC-F919CAAEFBAAQ34066200-D8CB27F1-A713-47FA-AB98-826DAFB19749Q34094501-F2A5176B-F741-46C0-8AA0-E3FF55D9F1B0Q34652071-519426A4-477C-47F1-B548-90759D760173Q35081055-532E11F4-9447-471B-ABBD-1C7831481131Q35141182-5E3B75FD-52FC-460C-B05D-822733AD044EQ35793607-B9195611-A985-497F-A903-AC2E29E62E50Q36057329-1B475331-5528-4D5D-A0CE-8D85175F8B36Q36076645-EBB9B372-5287-432A-ABCA-5CC507559DD9Q36136387-D9BE664E-3426-4C38-ADAC-C28C85B51F92Q36404535-138BBECD-9AD2-4EFD-819D-F291F0315D56Q36412428-9A34975F-04BF-4FBA-85FD-9F4963A203CEQ36780771-1A34BD6D-2715-4F53-83F3-5580B8F1DA6EQ36806639-9CDC3397-E03F-43DF-ADD5-B354CE67383CQ36942274-AB8BF4A1-D718-41C2-B485-9E0F13771D25Q36986449-D816AC59-ABE0-40DD-A04D-755517D39FB3Q37102982-6433F756-8422-48D7-B09D-E9385369DBBFQ37698598-09F4BF9E-AECE-4DF7-9BF5-7B9A6E5855B5Q37760418-D257127A-5BAE-47BD-8045-0C63D19EEC9BQ38184387-72A05DA2-7113-46FA-8179-E5968166FB46Q38200602-87E9CBB5-F723-4250-B246-6FBF3F770382Q38260539-B7F72348-27E7-4783-94F6-5A4CFBCF79A4Q39654179-0A880AE8-7471-4CBF-A108-4E92AEB75A7DQ40325570-E6A7BD46-B3E3-4DB3-A263-AF8DDC64B0BDQ41200344-88A6E1F8-6EA5-4CE5-9DE2-D08511832611Q41542097-1796597E-140F-4A6E-802F-E7ABA7B4A69AQ41822173-9F02C33A-CA10-4B76-815D-F166A37FEB5DQ42334782-B0E3A4E1-D77B-4C2C-BD55-FDC9E5C3151AQ42396970-AD3845EC-EC5A-4D66-9426-D065C2F27D26Q45228255-92CDA805-04D4-4458-98DD-163B75766BE4Q45625023-F4FF1C54-03EA-46EC-AA4E-D42F858B22B6Q45953234-9B1F7FF7-A56C-49D2-B8A7-2ED2201C969DQ46149035-8A048FD2-4103-4E3F-BE4A-55A1D52BEEDAQ47848241-FF72FBFC-280F-4ECC-BA32-8415A4F8E938Q47937645-8D94D477-7EC3-4EF8-B40E-2BD93F8D30BCQ48304352-BA1E14E8-13B9-49F2-B720-A632D8128E55
P2860
Alzheimer's disease is a vasocognopathy: a new term to describe its nature.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Alzheimer's disease is a vasocognopathy: a new term to describe its nature.
@ast
Alzheimer's disease is a vasocognopathy: a new term to describe its nature.
@en
type
label
Alzheimer's disease is a vasocognopathy: a new term to describe its nature.
@ast
Alzheimer's disease is a vasocognopathy: a new term to describe its nature.
@en
prefLabel
Alzheimer's disease is a vasocognopathy: a new term to describe its nature.
@ast
Alzheimer's disease is a vasocognopathy: a new term to describe its nature.
@en
P2860
P1476
Alzheimer's disease is a vasocognopathy: a new term to describe its nature.
@en
P2093
Jack C de la Torre
P2860
P304
P356
10.1179/016164104225016254
P577
2004-07-01T00:00:00Z